Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Philip J Pedersen"'
Autor:
Jason A West, Anastasia Tsakmaki, Soumitra S Ghosh, David G Parkes, Rikke V Grønlund, Philip J Pedersen, David Maggs, Harith Rajagopalan, Gavin A Bewick
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0249239 (2021)
Combinatorial gut hormone therapy is one of the more promising strategies for identifying improved treatments for metabolic disease. Many approaches combine the established benefits of glucagon-like peptide-1 (GLP-1) agonism with one or more addition
Externí odkaz:
https://doaj.org/article/0d79c9bba3884a64acb17d2b7e8c1e7b
Autor:
Pernille Barkholt, Philip J. Pedersen, Anders Hay-Schmidt, Jacob Jelsing, Henrik H. Hansen, Niels Vrang
Publikováno v:
Molecular Metabolism, Vol 5, Iss 4, Pp 296-304 (2016)
Objective: The role of the central nervous system in mediating metabolic effects of Roux-en-Y gastric bypass (RYGB) surgery is poorly understood. Using a rat model of RYGB, we aimed to identify changes in gene expression of key hypothalamic neuropept
Externí odkaz:
https://doaj.org/article/cb19a6d40c254da7bd45952374619e92
Autor:
Christine Scott Lunddahl, Philip J. Pedersen, Rikke Buhl, Dagmar S Trachsel, Elin J Rgensen, Dan A. Klaerke, Kirstine Calloe, J Rgen K Kanters
Publikováno v:
American Journal of Veterinary Research. 82:207-217
OBJECTIVE To determine whether administration of trimethoprim-sulfadiazine (TMS), detomidine (DET), or TMS plus DET would be associated with changes in ECG repolarization parameters in horses. ANIMALS 9 healthy adult horses. PROCEDURES Each horse rec
Autor:
Lisbeth Nielsen Fink, Nina Buch-Månson, Knud J. Jensen, Narendra Kumar Mishra, Niels Vrang, Søren L. Pedersen, Karin Mannerstedt, Keld Fosgerau, Thomas Brimert, Philip J. Pedersen, Priska Le-Huu, Charlotte Madsen, Ebbe Engholm, Björn Borgström, Morten Lundh
Publikováno v:
Chemistry – A European Journal. 27:3166-3176
A glucose responsive insulin (GRI) that responds to changes in blood glucose concentrations has remained an elusive goal. Here we describe the development of glucose cleavable linkers based on hydrazone and thiazolidine structures. We developed linke
Autor:
Louise S Dalbøge, Philip J Pedersen, Gitte Hansen, Katrine Fabricius, Henrik B Hansen, Jacob Jelsing, Niels Vrang
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135634 (2015)
Unlike rats and mice, hamsters develop hypercholesterolemia, and hypertriglyceridemia when fed a cholesterol-rich diet. Because hyperlipidemia is a hallmark of human obesity, we aimed to develop and characterize a novel diet-induced obesity (DIO) and
Externí odkaz:
https://doaj.org/article/c71f9205a59d47268432a13b2c285b66
Autor:
Rikke V. Grønlund, Harith Rajagopalan, Anastasia Tsakmaki, Jason A. West, David G. Parkes, David Maggs, Philip J. Pedersen, Soumitra S. Ghosh, Gavin A. Bewick
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0249239 (2021)
PLoS ONE
PLoS ONE
Combinatorial gut hormone therapy is one of the more promising strategies for identifying improved treatments for metabolic disease. Many approaches combine the established benefits of glucagon-like peptide-1 (GLP-1) agonism with one or more addition
Autor:
Thomas Secher, Philip J. Pedersen, Jacob Jelsing, Lisbeth Nielsen Fink, Louise Thisted, Andrew J. Murray, Sebastian T. Thrane, Nora E. Zois, Tanja X. Pedersen, Torben Skarsfeldt, Morten B. Thomsen, Thea T. Johansen, Ross T. Lindsay, Mette V. Østergaard, Annemarie A. Pedersen
Publikováno v:
Thisted, D L A, Østergaard, M V, Pedersen, A A, Pedersen, P J, Lindsay, R T, Murray, A J, Fink, L N, Pedersen, T X, Secher, T, Johansen, T T, Thrane, S T, Skarsfeldt, T, Jelsing, J, Thomsen, M B & Zois, N E 2020, ' Rat pancreatectomy combined with isoprenaline or uninephrectomy as models of diabetic cardiomyopathy or nephropathy ', Scientific Reports, vol. 10, 16130 . https://doi.org/10.1038/s41598-020-73046-8
Scientific Reports, Vol 10, Iss 1, Pp 1-15 (2020)
Thisted, L, Ostergaard, M, Pedersen, A A, Pedersen, P J, Lindsay, R T, Murray, A J, Fink, L N, Pedersen, T X, Secher, T, Johansen, T T, Thrane, S T, Skarsfeldt, T, Jelsing, J, Thomsen, M B & Zois, N E 2020, ' Rat pancreatectomy combined with isoprenaline or uninephrectomy as models of diabetic cardiomyopathy or nephropathy ', Scientific Reports, vol. 10, no. 1, 16130 . https://doi.org/10.1038/s41598-020-73046-8
Scientific Reports, Vol 10, Iss 1, Pp 1-15 (2020)
Thisted, L, Ostergaard, M, Pedersen, A A, Pedersen, P J, Lindsay, R T, Murray, A J, Fink, L N, Pedersen, T X, Secher, T, Johansen, T T, Thrane, S T, Skarsfeldt, T, Jelsing, J, Thomsen, M B & Zois, N E 2020, ' Rat pancreatectomy combined with isoprenaline or uninephrectomy as models of diabetic cardiomyopathy or nephropathy ', Scientific Reports, vol. 10, no. 1, 16130 . https://doi.org/10.1038/s41598-020-73046-8
Cardiovascular and renal complications are the predominant causes of morbidity and mortality amongst patients with diabetes. Development of novel treatments have been hampered by the lack of available animal models recapitulating the human disease. W
Autor:
Keld Fosgerau, Philip J. Pedersen, Jacob Jelsing, Niels Vrang, Urmas Roostalu, Nora E. Zois, Louise Thisted
Publikováno v:
Diabetes. 69
Introduction: Patients with diabetes have an increased risk of cardiovascular disease including myocardial infarction (MI). A major consequence of MI is left ventricular (LV) remodeling including compensatory hypertrophy without concomitant adaptatio
Autor:
Louise, Thisted, Mette V, Østergaard, Annemarie A, Pedersen, Philip J, Pedersen, Ross T, Lindsay, Andrew J, Murray, Lisbeth N, Fink, Tanja X, Pedersen, Thomas, Secher, Thea T, Johansen, Sebastian T, Thrane, Torben, Skarsfeldt, Jacob, Jelsing, Morten B, Thomsen, Nora E, Zois
Publikováno v:
Scientific reports. 10(1)
Cardiovascular and renal complications are the predominant causes of morbidity and mortality amongst patients with diabetes. Development of novel treatments have been hampered by the lack of available animal models recapitulating the human disease. W
Autor:
Keld Fosgerau, Palle Jeppesen, Gitte Hansen, Karin Mannerstedt, Søren L. Pedersen, Pernille Wismann, Niels Vrang, Jacob Jelsing, Philip J. Pedersen
Publikováno v:
Physiology & Behavior. 192:72-81
Aim Analogues of several gastrointestinal peptide hormones have been developed into effective medicines for treatment of diseases such as type 2 diabetes mellitus (T2DM), obesity and short bowel syndrome (SBS). In this study, we aimed to explore whet